CSL Limited (ASX:CSL) Stock Today: Buyback Update, Share Price Action and Outlook – 27 November 2025
CSL Limited enters the final month of 2025 still nursing one of the toughest years in its history. After profit downgrades, a delayed vaccine spin‑off and a brutal share-price slump, the biotech giant is leaning on a A$750 million on‑market buyback and fresh investment plans to steady investor nerves.